Blackstone Inc Relay Therapeutics, Inc. Transaction History
Blackstone Inc
- $20.1 Billion
- Q4 2024
A detailed history of Blackstone Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Blackstone Inc holds 35,618 shares of RLAY stock, worth $142,472. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,618
Previous 35,618
-0.0%
Holding current value
$142,472
Previous $252,000
42.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
208Shares Held
162MCall Options Held
102KPut Options Held
28.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$112 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$60.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$42.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$35.8 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$32.3 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $481M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...